Clinical expressions, characteristics and treatments of confirmed COVID-19 in nursing home residents: a systematic review
- PMID: 36803435
- PMCID: PMC9936944
- DOI: 10.1186/s12877-023-03826-0
Clinical expressions, characteristics and treatments of confirmed COVID-19 in nursing home residents: a systematic review
Abstract
Background: The coronavirus 2019 (COVID-19) pandemic has led to a high rate of infections, frequent outbreaks, and high mortality rates in nursing homes (NH) worldwide. To protect and improve the treatment and care of the vulnerable NH population, it is pivotal to systematise and synthesise data from cases of COVID-19 among NH residents. In our systematic review, we therefore aimed to describe the clinical expressions, characteristics, and treatments of NH residents confirmed to have COVID-19.
Methods: We conducted two comprehensive literature searches in several electronic databases: (1) PubMed, (2) CINAHL, (3) AgeLine, (4) Embase, and (5) PsycINFO in April and July 2021. Of the 438 articles screened, 19 were included in our sample, and we used the Newcastle-Ottawa Assessment Scale to assess the quality of the reported studies. A weighted mean (Mweighted), was calculated to account for the large variation in sample sizes of the studies, and due to heterogeneity among the studies, we report our findings in a narrative synthesis.
Results: According to the mean weights (Mweighted), common symptoms and signs in NH residents confirmed to have COVID-19 were fever (53.7%), cough (56.5%), hypoxia (32.3%), and delirium or confusion (31.2%). Common comorbidities were hypertension (78.6%), dementia or cognitive impairment (55.3%), and cardiovascular diseases (52.0%). Six studies presented data concerning medical and pharmacological treatments, such as inhalers, oxygen supplementation, anticoagulation, and parenteral/enteral fluids or nutrition. The treatments were used to improve outcomes, as part of palliative care, or as end-of-life treatment. Transfers to hospital for NH residents with confirmed COVID-19 were reported in six of the included studies, and the rate of hospital transfers ranged from 6.9% to 50% in this population. In the 17 studies reporting mortality, 40.2% of the NH residents died during the studies' observation periods.
Conclusions: Our systematic review allowed us to summarise important clinical findings about COVID-19 among NH residents and to identify the population's risk factors for serious illness and death caused by the disease. However, the treatment and care of NH residents with severe COVID-19 warrant further investigation.
Keywords: COVID-19; Comorbidity; Mortality; Nursing home; Older adult; Symptom.
© 2023. The Author(s).
Conflict of interest statement
The authors have no competing interests to declare that are relevant to the content of this article.
Figures
Similar articles
-
COVID-19 Outbreaks in Nursing Homes Despite Full Vaccination with BNT162b2 of a Majority of Residents.Gerontology. 2022;68(12):1384-1392. doi: 10.1159/000523701. Epub 2022 Mar 21. Gerontology. 2022. PMID: 35313315 Free PMC article.
-
Mortality and the Use of Antithrombotic Therapies Among Nursing Home Residents with COVID-19.J Am Geriatr Soc. 2020 Aug;68(8):1647-1652. doi: 10.1111/jgs.16664. Epub 2020 Jul 21. J Am Geriatr Soc. 2020. PMID: 32633418 Free PMC article.
-
A systematic review of prevalence of pain in nursing home residents with dementia.BMC Geriatr. 2023 Oct 10;23(1):641. doi: 10.1186/s12877-023-04340-z. BMC Geriatr. 2023. PMID: 37817061 Free PMC article.
-
Risk Factors Associated With All-Cause 30-Day Mortality in Nursing Home Residents With COVID-19.JAMA Intern Med. 2021 Apr 1;181(4):439-448. doi: 10.1001/jamainternmed.2020.7968. JAMA Intern Med. 2021. PMID: 33394006 Free PMC article.
-
Urinary Incontinence Is Associated With Increased All-Cause Mortality in Older Nursing Home Residents: A Meta-Analysis.J Nurs Scholarsh. 2021 Sep;53(5):561-567. doi: 10.1111/jnu.12671. Epub 2021 May 22. J Nurs Scholarsh. 2021. PMID: 34021695
Cited by
-
Treatment and Care for Nursing Home Residents with COVID-19: A Qualitative Study.J Multidiscip Healthc. 2024 Jun 20;17:2935-2946. doi: 10.2147/JMDH.S467459. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38933696 Free PMC article.
References
-
- World Health Organization. Timeline: WHO's COVID-19 response. 2022; https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interact... Accessed 26 Apr 2022.
-
- Norwegian Institute of Public Health. Facts about the SARS-CoV-2 virus and COVID-19 disease. 2022; https://www.fhi.no/en/op/novel-coronavirus-facts-advice/facts-and-knowle... Accessed 27 Apr 2022.
-
- World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2022; https://covid19.who.int/ Accessed 23 Aug 2022.
-
- Norwegian Institute of Public Health. Coronavirus vaccine - information for the public. 2022; https://www.fhi.no/en/id/vaccines/coronavirus-immunisation-programme/cor... Accessed 26 Apr 2022.
-
- World Health Organization. COVID-19 vaccines. 2022; https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19... Accessed 27 Apr 2022.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous